Home
About
Overview
Sharing Data
ORCID
Help
History (25)
Unveiling the potential of gene editing techniques in revolutionizing Cancer treatment: A comprehensive overview.
Progressive Neurologic Changes in a Patient With Metastatic Non-Small-Cell Lung Cancer: Cancer Effects or a Secondary Diagnosis?
SOX9: The master regulator of cell fate in breast cancer.
Transactivation of the receptor-tyrosine kinase ephrin receptor A2 is required for the low molecular weight hyaluronan-mediated angiogenesis that is implicated in tumor progression.
Maintenance therapy in NSCLC: why? To whom? Which agent?
See All 25 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Maintenance therapy in NSCLC: why? To whom? Which agent?
Maintenance therapy in NSCLC: why? To whom? Which agent? J Exp Clin Cancer Res. 2011 May 06; 30:50.
View in:
PubMed
subject areas
Antineoplastic Agents
Carcinoma, Non-Small-Cell Lung
Clinical Trials as Topic
Humans
Lung Neoplasms
authors with profiles
Marina Chiara Garassino